Journal of Cancer,
Journal Year:
2023,
Volume and Issue:
14(9), P. 1499 - 1514
Published: Jan. 1, 2023
Lung
squamous
cell
carcinoma
has
so
far
lacked
effective
targets
for
diagnosis
and
treatment.
In
cancer
research,
long
noncoding
RNAs
(LncRNAs)
emerge
as
novel
therapeutic
biomarkers.
Cuprophosis
is
a
new
death
type
involving
multiple
biological
processes
in
tumor
cells.
Here,
we
aimed
to
explore
whether
Cuprophosis-related
lncRNAs
could
be
used
predict
prognosis,
assess
immune
function,
test
drug
sensitivity
LUSC
patients.
The
Cancer
Genome
Map
(TCGA)
was
obtain
genome
clinical
data,
Cuprophosis-relevant
genes
were
found
the
literature.
A
cuproptosis-related
lncRNA
risk
model
built
using
co-expression
analysis,
univariate/multivariate
Cox
regression,
LASSO
analysis.
survival
analysis
model's
prognostic
value.
univariate
multivariate
regression
analyses
performed
determine
score,
age,
gender,
or
stages
independent
factors.
Gene
Set
Enrichment
Analysis
mutation
on
differentially
expressed
mRNA
between
high-risk
low-risk
groups.
(TIDE)
algorithm
conduct
immunological
functional
testing.
Five
LncRNAs
identified,
selected
constructed
prognosis
model.
According
Kaplan-Meier
overall
time
patients
group
shorter
than
those
group.
For
patients,
score
serves
an
indicator.
GO
KEGG
enrichment
revealed
that
mRNAs
high-
groups
enriched
several
immune-related
processes.
of
higher
function
pathways,
including
IFN-γ
MHC
I
pathways.
Tumor
Immune
Dysfunction
Exclusion
more
likely
experience
escape.
showed
with
ratings
respond
GW441756
Salubrinal.
contrast,
scores
responsive
dasatinib
Z-LLNIe
CHO.
5-Cuprophosis-related
signature
can
Molecular Cancer,
Journal Year:
2023,
Volume and Issue:
22(1)
Published: March 7, 2023
Abstract
Cuproptosis
was
a
copper-dependent
and
unique
kind
of
cell
death
that
separate
from
existing
other
forms
death.
The
last
decade
has
witnessed
considerable
increase
in
investigations
programmed
death,
whether
copper
induced
an
independent
form
long
been
argued
until
mechanism
cuproptosis
revealed.
After
that,
increasing
number
researchers
attempted
to
identify
the
relationship
between
process
cancer.
Thus,
this
review,
we
systematically
detailed
systemic
cellular
metabolic
processes
copper-related
tumor
signaling
pathways.
Moreover,
not
only
focus
on
discovery
its
mechanism,
but
also
outline
association
cancers.
Finally,
further
highlight
possible
therapeutic
direction
employing
ion
ionophores
with
cuproptosis-inducing
functions
combination
small
molecule
drugs
for
targeted
therapy
treat
specific
Frontiers in Oncology,
Journal Year:
2023,
Volume and Issue:
13
Published: March 23, 2023
Copper
is
an
essential
micronutrient
for
human
body
and
plays
a
vital
role
in
various
biological
processes
including
cellular
respiration
free
radical
detoxification.
Generally,
copper
metabolism
the
stable
state,
there
are
specific
mechanisms
to
regulate
maintain
homeostasis.
Dysregulation
of
may
have
great
connection
with
types
diseases,
such
as
Wilson
disease
causing
overload
Menkes
deficiency.
Cancer
presents
high
mortality
rates
world
due
unlimited
proliferation
potential,
apoptosis
escape
immune
properties
induce
organ
failure.
thought
cancer,
elevated
levels
cancer
tissue
serum.
also
affects
tumor
progression
by
affecting
angiogenesis,
metastasis
other
processes.
Notably,
cuproptosis
novel
form
cell
death
that
provide
targeting
strategies
developing
therapy.
chelators
ionophores
two
coordinating
compounds
treatment
cancer.
This
review
will
explore
relationship
between
cancers,
clarify
targeted
Heliyon,
Journal Year:
2024,
Volume and Issue:
10(5), P. e27496 - e27496
Published: March 1, 2024
Copper,
a
vital
trace
element,
orchestrates
diverse
cellular
processes
ranging
from
energy
production
to
antioxidant
defense
and
angiogenesis.
Copper
metabolism
cuproptosis
are
closely
linked
in
the
context
of
human
diseases,
with
particular
focus
on
cancer.
Cuproptosis
refers
specific
type
copper-mediated
cell
death
or
copper
toxicity
triggered
by
disruptions
within
cells.
This
phenomenon
encompasses
spectrum
mechanisms,
such
as
oxidative
stress,
mitochondrial
dysfunction,
endoplasmic
reticulum
perturbations
metal
ion
equilibrium.
Mechanistically,
is
driven
binding
lipoylated
enzymes
tricarboxylic
acid
(TCA)
cycle.
interaction
participates
protein
aggregation
proteotoxic
ultimately
culminating
death.
Targeting
its
associated
pathways
cancer
cells
holds
therapeutic
potential
selectively
targeting
eliminating
cancerous
Strategies
modulate
levels,
enhance
excretion,
interfere
cuproptotic
being
explored
identify
novel
targets
for
therapy
improve
patient
outcomes.
Understanding
relationship
between
malignancies
remains
an
active
area
research.
review
provides
comprehensive
overview
association
metabolism,
homeostasis,
cancers,
explicitly
emphasizing
mechanism
implications
pathogenesis.
Additionally,
we
emphasize
aspects
treatment.
Clinical and Experimental Medicine,
Journal Year:
2024,
Volume and Issue:
24(1)
Published: Sept. 26, 2024
Abstract
Long
non-coding
RNAs
(lncRNAs)
have
emerged
as
crucial
regulators
in
various
cellular
processes,
including
cancer
progression
and
stress
response.
Recent
studies
demonstrated
that
copper
accumulation
induces
a
unique
form
of
cell
death
known
cuproptosis,
with
lncRNAs
playing
key
role
regulating
cuproptosis-associated
pathways.
These
may
trigger
cell-specific
responses
to
stress,
presenting
new
opportunities
prognostic
markers
therapeutic
targets.
This
paper
delves
into
the
cuproptosis-mediated
cancer,
underscoring
their
potential
biomarkers
targets
for
innovative
strategies.
A
thorough
review
scientific
literature
was
conducted,
utilizing
databases
such
PubMed,
Google
Scholar,
ScienceDirect,
search
terms
like
'lncRNAs,'
'cuproptosis,'
'cancer.'
Studies
were
selected
based
on
relevance
lncRNA
regulation
cuproptosis
pathways
implications
prognosis
treatment.
The
highlights
significant
contribution
cuproptosis-related
genes
pathways,
impacting
metabolism,
mitochondrial
responses,
apoptotic
signaling.
Specific
are
breast,
lung,
liver,
ovarian,
pancreatic,
gastric
cancers.
objective
this
article
is
explore
cancers
mediated
by
cuproptosis.
Biomedicine & Pharmacotherapy,
Journal Year:
2024,
Volume and Issue:
176, P. 116874 - 116874
Published: June 7, 2024
Copper,
an
indispensable
micronutrient,
is
implicated
in
numerous
vital
biological
processes
and
essential
for
all
physiological
activities.
Recently,
the
discovery
of
a
novel
type
copper-dependent
cell
death,
known
as
cuproptosis,
has
shed
light
on
its
role
cancer
development.
Extensive
research
currently
underway
to
unravel
mechanisms
underlying
cuproptosis
correlation
with
various
types.
In
this
review,
we
summarize
findings
regarding
roles
types,
including
colorectal
cancer,
lung
gastric
breast
liver
cutaneous
melanoma.
Furthermore,
effects
copper-related
agents
such
copper
chelators
ionophores
proliferation,
apoptosis,
angiogenesis,
tumor
immunity,
chemotherapy
resistance
have
been
explored
preclinical
clinical
trials.
These
insights
provide
promising
avenues
development
prospective
anticancer
drugs
aimed
at
inducing
cuproptosis.
Genes,
Journal Year:
2022,
Volume and Issue:
13(12), P. 2214 - 2214
Published: Nov. 25, 2022
Background:
One
of
the
most
frequent
malignancies
digestive
system
is
stomach
adenocarcinoma
(STAD).
Recent
research
has
demonstrated
how
cuproptosis
(copper-dependent
cell
death)
differs
from
other
death
mechanisms
that
were
previously
understood.
Cuproptosis
regulation
in
tumor
cells
could
be
a
brand-new
treatment
strategy.
Our
goal
was
to
create
cuproptosis-related
lncRNA
signature.
Additionally,
order
evaluate
possible
immunotherapeutic
advantages
and
drug
sensitivity,
we
attempted
study
association
between
these
lncRNAs
immune
microenvironment
STAD
tumors.
Methods:
The
TCGA
database
accessed
download
RNA
sequencing
data,
genetic
mutations,
clinical
profiles
for
STAD.
To
locate
related
build
risk-prognosis
models,
three
techniques
used:
co-expression
network
analysis,
Cox-regression
techniques,
LASSO
techniques.
an
integrated
methodology
used
validate
models’
predictive
capabilities.
Then,
using
GO
KEGG
discovered
variations
biological
functions
each
group.
link
risk
score
various
medications
estimated
mutational
load
(TMB)
dysfunction
rejection
(TIDE)
scores.
Result:
We
gathered
22
genes
linked
based
on
prior
literature.
Six
prognostic
marker
(AC016394.2,
AC023511.1,
AC147067.2,
AL590705.3,
HAGLR,
LINC01094).
After
that,
patients
split
into
high-risk
low-risk
groups.
A
statistically
significant
difference
overall
survival
two
groups
visible
curves.
independent
factor
affecting
prognosis
by
both
univariate
multivariate
Cox
regression
analysis.
Different
scores
substantially
immunological
states
patients,
as
further
evidenced
infiltration
ssGSEA
had
differing
burdens
mutations.
In
addition,
immunotherapy
more
effective
group
than
group,
connected
with
medication
sensitivity.
Conclusions:
six
cuproptosis-associated
predictors,
which
may
useful
biomarkers
stratification,
evaluation
immunotherapy,
assessment
sensitivity
Frontiers in Immunology,
Journal Year:
2022,
Volume and Issue:
13
Published: Nov. 28, 2022
Introduction
Breast
cancer
(BC)
has
been
ranking
first
in
incidence
and
the
leading
cause
of
death
among
female
cancers
worldwide
based
on
latest
report.
Regulated
cell
(RCD)
plays
a
significant
role
tumor
initiation
provides
an
important
target
treatment.
Cuproptosis,
novel
form
RCD,
is
ignited
by
mitochondrial
stress,
particularly
lipoylated
enzymes
aggregation.
However,
cuproptosis-related
genes
(CRGs)
generation
progression
remains
unclear.
Methods
In
this
study,
mRNA
expression
data
CRGs
BC
normal
breast
tissue
were
extracted
from
TCGA
database,
protein
patterns
these
analyzed
using
UALCAN.
The
prognostic
values
explored
KaplanMeier
plotter
Cox
regression
analysis.
Genetic
mutations
profiles
evaluated
cBioPortal
database.
Meanwhile,
we
utilized
CIBERSORT
TIMER
2.0
database
to
perform
correlation
analysis
between
immune
infiltration.
Results
Our
results
indicated
that
significantly
different
tissues.
Then
found
upregulated
PDHA1
was
associated
with
worse
endpoint
BC.
Moreover,
also
performed
infiltration
CRGs,
demonstrated
closely
related
levels
CD4+
memory
T
cell,
macrophage
M0
M1
mast
Conclusions
immunogenetic
Therefore,
can
be
independent
biomarker
potential
for
immunotherapy
European journal of medical research,
Journal Year:
2023,
Volume and Issue:
28(1)
Published: May 15, 2023
Abstract
Kidney
renal
clear
cell
carcinoma
(KIRC)
is
a
main
subtype
of
kidney
cancers.
Cuproptosis
and
ferroptosis
are
correlated
with
immune
infiltration
prognosis
in
tumors.
However,
the
role
Cuproptosis-related
Ferroptosis
genes
(CRFGs)
KIRC
has
rarely
been
fully
understood.
Therefore,
we
constructed
prognostic
signature
based
on
different
expression
CRFGs
KIRC.
All
raw
data
this
study
were
extracted
from
public
TCGA
datasets.
collected
previous
research.
Finally,
total
36
significantly
identified
TCGA–KIRC
cohort.
Six-gene
(
TRIB3
,
SLC2A3
PML
CD44
CDKN2A
MIOX
)
was
by
LASSO
Cox
regression
CRFGs.
The
worse
overall
survival
AUC
0.750.
Functional
enrichment
indicated
that
mainly
enriched
metabolism,
drug
resistance,
tumor
immunity
pathways.
Besides,
IC50
checkpoint
differentially
expressed
between
groups.
proposed
6-CRFGs
promising
biomarker
to
predict
clinical
outcomes
therapeutic
responses
for
patient.
Frontiers in Endocrinology,
Journal Year:
2024,
Volume and Issue:
15
Published: March 4, 2024
Background
PANoptosis
is
a
newly
discovered
cell
death
type,
and
tightly
associated
with
immune
system
activities.
To
date,
the
mechanism,
regulation
application
of
in
tumor
largely
unknown.
Our
aim
to
explore
prognostic
value
PANoptosis-related
genes
colon
adenocarcinoma
(COAD).
Methods
Analyzing
data
from
The
Cancer
Genome
Atlas-COAD
(TCGA-COAD)
involving
458
COAD
cases,
we
concentrated
on
five
pathways
Molecular
Signatures
Database
(MSigDB)
comprehensive
set
immune-related
genes.
approach
involved
identifying
distinct
genetic
subtype
clusters
developing
model
based
these
parameters.
Results
research
successfully
identified
two
COAD,
marked
by
profiles
gene
expression.
A
model,
incorporating
findings,
demonstrated
significant
predictive
power
for
survival
outcomes,
underscoring
interplay
between
responses
COAD.
Conclusion
This
study
enhances
our
understanding
COAD’s
framework,
emphasizing
synergy
system.
development
insights
offers
promising
tool
personalized
treatment
strategies.
Future
should
focus
validating
refining
this
clinical
settings
optimize
therapeutic
interventions